These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 9364673

  • 1. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR.
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP.
    Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228
    [Abstract] [Full Text] [Related]

  • 4. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
    Gupta RK, Chang AC, Griffin P, Rivera R, Siber GR.
    Vaccine; 1996 Oct 27; 14(15):1412-6. PubMed ID: 8994315
    [Abstract] [Full Text] [Related]

  • 5. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
    He Y, Chen ZH, Wei SL.
    Yao Xue Xue Bao; 2001 Sep 27; 36(9):695-8. PubMed ID: 12580111
    [Abstract] [Full Text] [Related]

  • 6. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T, Koneberg R, Hungerer KD, Kissel T.
    Int J Pharm; 2002 Mar 02; 234(1-2):75-90. PubMed ID: 11839439
    [Abstract] [Full Text] [Related]

  • 7. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ, Gupta RK, Min C, Siber GR, Langer R.
    Vaccine; 1994 Mar 02; 12(4):299-306. PubMed ID: 8178550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determinants of release rate of tetanus vaccine from polyester microspheres.
    Alonso MJ, Cohen S, Park TG, Gupta RK, Siber GR, Langer R.
    Pharm Res; 1993 Jul 02; 10(7):945-53. PubMed ID: 8378256
    [Abstract] [Full Text] [Related]

  • 10. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A, Villamayor B, Guo Y, McIver J, Alonso MJ.
    Int J Pharm; 1999 Aug 20; 185(2):255-66. PubMed ID: 10460920
    [Abstract] [Full Text] [Related]

  • 11. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
    Tobío M, Schwendeman SP, Guo Y, McIver J, Langer R, Alonso MJ.
    Vaccine; 1999 Nov 12; 18(7-8):618-22. PubMed ID: 10547420
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
    Johansen P, Moon L, Tamber H, Merkle HP, Gander B, Sesardic D.
    Vaccine; 1999 Sep 12; 18(3-4):209-15. PubMed ID: 10506644
    [Abstract] [Full Text] [Related]

  • 13. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS, Katare YK, Lalwani K, Ali MM, Singh O, Panda AK.
    Int J Pharm; 2002 Oct 01; 245(1-2):109-21. PubMed ID: 12270248
    [Abstract] [Full Text] [Related]

  • 14. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, Kissel T.
    Pharm Res; 2001 Mar 01; 18(3):352-60. PubMed ID: 11442276
    [Abstract] [Full Text] [Related]

  • 15. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
    Tobío M, Nolley J, Guo Y, McIver J, Alonso MJ.
    Pharm Res; 1999 May 01; 16(5):682-8. PubMed ID: 10350011
    [Abstract] [Full Text] [Related]

  • 16. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
    Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B.
    Pharm Res; 1998 Jul 01; 15(7):1103-10. PubMed ID: 9688067
    [Abstract] [Full Text] [Related]

  • 17. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
    Men Y, Gander B, Merkle HP, Corradin G.
    Vaccine; 1996 Oct 01; 14(15):1442-50. PubMed ID: 8994320
    [Abstract] [Full Text] [Related]

  • 18. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.
    Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V.
    J Microencapsul; 2001 Oct 01; 18(6):723-32. PubMed ID: 11695637
    [Abstract] [Full Text] [Related]

  • 19. Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.
    Audran R, Men Y, Johansen P, Gander B, Corradin G.
    Pharm Res; 1998 Jul 01; 15(7):1111-6. PubMed ID: 9688068
    [Abstract] [Full Text] [Related]

  • 20. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
    Frangione-Beebe M, Rose RT, Kaumaya PT, Schwendeman SP.
    J Microencapsul; 2001 Jul 01; 18(5):663-77. PubMed ID: 11508771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.